Abstract
The Joint Section on Tumors of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons is now in its 30th year. In many ways its growth and development has paralleled neurosurgery and medicine as a whole. This is most evident in our endeavor towards more patient-centered care and focus on quantity and quality of life. As the push towards evidence-based care continues, it is important to ensure that individualized care remains a guiding principle. Conscientious surgeons continue to refine techniques and develop technologies that push the boundaries of surgical efficacy while better defining the risks of surgery and the impacts of surgical complications. This article provides a review of the factors involved in minimizing risk and obtaining maximal outcomes for patients through insightful patient selection and evidence-based surgical decision-making. Herein, we present the philosophy and practice of the Hermelin Brain Tumor Center at the Henry Ford Health System as one type of approach to caring for the patient with a malignant glioma.
Similar content being viewed by others
References
Knapp PC (1891) The pathology, diagnosis and treatment of intra-cranial growths. Rockwell & Churchill, Boston
Knapp PC (1891) A contribution from brain surgery to the study of the localization of the sensory centres in the cerebral cortex. Boston Med Surg J 125:430–433
Sanai N, Berger MS (2012) Recent surgical management of gliomas. Adv Exp Med Biol 746:12–25
Sanai N, Polley M-Y, McDermott MW, Parsa AT, Berger MS (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115:3–8
Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198
Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen H-J, ALA-Glioma Study Group (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392–401
Stummer W, van den Bent MJ, Westphal M (2011) Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion. Acta Neurochir (Wien) 153:1211–1218
McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD, Quinones-Hinojosa A (2009) Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery 65:463–469; discussion 469–470
Yong RL, Lonser RR (2011) Surgery for glioblastoma multiforme: striking a balance. World Neurosurg 76:528–530
Gulati S, Jakola AS, Nerland US, Weber C, Solheim O (2011) The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma. World Neurosurg 76:572–579
Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi WM, Wildrick DM (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044–1055; discussion 1055–1056
Chang SM, Parney IF, McDermott M et al (2003) Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg 98:1175–1181
Kreth FW, Warnke PC, Scheremet R, Ostertag CB (1993) Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78:762–766
Mehdorn HM, Schwartz F, Dawirs S, Hedderich J, Dörner L, Nabavi A (2011) High-field iMRI in glioblastoma surgery: improvement of resection radicality and survival for the patient? Acta Neurochir Suppl (Wien) 109:103–106
Keles GE, Anderson B, Berger MS (1999) The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 52:371–379
Barker FG 2nd, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB (1998) Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42:709–720; discussion 720–723
Ciric I, Ammirati M, Vick N, Mikhael M (1987) Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection. Neurosurgery 21:21–26
Eyüpoglu IY, Buchfelder M, Savaskan NE (2013) Surgical resection of malignant gliomas-role in optimizing patient outcome. Nat Rev Neurol 9:141–151
Pichlmeier U, Bink A, Schackert G, Stummer W, ALA Glioma Study Group (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro-Oncol 10:1025–1034
Van den Bent MJ, Stupp R, Mason WP, Mirimanoff R, Lacombe D, Gorlia T Impact of extent of resection on overall survival in newly-diagnosed glioblastoma after chemo-irradiation with temozolomide: further analysis of EORTC study 26981 (abstract)
Vuorinen V, Hinkka S, Färkkilä M, Jääskeläinen J (2003) Debulking or biopsy of malignant glioma in elderly people—a randomised study. Acta Neurochir (Wien) 145:5–10
McGirt MJ, Chaichana KL, Gathinji M et al (2009) Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 110:156–162
Duffau H, Mandonnet E (2013) The “onco-functional balance” in surgery for diffuse low-grade glioma: integrating the extent of resection with quality of life. Acta Neurochir (Wien) 155:951–957
Díaz JL, Barreto P, Gallego JM, Barbero J, Bayés R, Barcia JA (2009) Proper information during the surgical decision-making process lowers the anxiety of patients with high-grade gliomas. Acta Neurochir (Wien) 151:357–362
Laws ER, Parney IF, Huang W et al (2003) Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99:467–473
Glantz MJ, Burger PC, Herndon JE 2nd, Friedman AH, Cairncross JG, Vick NA, Schold SC Jr (1991) Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 41:1741–1744
Stendel R (2009) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 64:E1206; author reply E1206
De Witt Hamer PC, Hendriks EJ, Mandonnet E, Barkhof F, Zwinderman AH, Duffau H (2013) Resection probability maps for quality assessment of glioma surgery without brain location bias. PLoS ONE 8:e73353
Wilson C (1990) Glioblastoma: the past, the present, and the future. Clinical Neurosurgery. Williams & Wilkins, Los Angeles
Earnest F 4th, Kelly PJ, Scheithauer BW et al (1988) Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 166:823–827
Kim EY, Yechieli R, Kim JK et al (2014) Patterns of failure after radiosurgery to two different target volumes of enhancing lesions with and without FLAIR abnormalities in recurrent glioblastoma multiforme. J Neurooncol 116:291–297
Orringer DA, Golby A, Jolesz F (2012) Neuronavigation in the surgical management of brain tumors: current and future trends. Expert Rev Med Devices 9:491–500
Narang J, Jain R, Arbab AS et al (2011) Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion. Neuro-Oncol 13:1037–1046
Jolesz FA, Kikinis R, Talos IF (2001) Neuronavigation in interventional MR imaging. Frameless stereotaxy. Neuroimaging Clin N Am 11:685–693, ix
Hartkens T, Hill DLG, Castellano-Smith AD et al (2003) Measurement and analysis of brain deformation during neurosurgery. IEEE Trans Med Imaging 22:82–92
Zakhary R, Keles GE, Berger MS (1999) Intraoperative imaging techniques in the treatment of brain tumors. Curr Opin Oncol 11:152–156
Nimsky C, Ganslandt O, Tomandl B, Buchfelder M, Fahlbusch R (2002) Low-field magnetic resonance imaging for intraoperative use in neurosurgery: a 5-year experience. Eur Radiol 12:2690–2703
Schackert G, Steinmetz A, Meier U, Sobottka SB (2001) Surgical management of single and multiple brain metastases: results of a retrospective study. Onkologie 24:246–255
Sanai N, Berger MS (2008) Mapping the horizon: techniques to optimize tumor resection before and during surgery. Clin Neurosurg 55:14–19
Sanai N, Mirzadeh Z, Berger MS (2008) Functional outcome after language mapping for glioma resection. N Engl J Med 358:18–27
Duffau H, Capelle L, Sichez N, Denvil D, Lopes M, Sichez J-P, Bitar A, Fohanno D (2002) Intraoperative mapping of the subcortical language pathways using direct stimulations an anatomo-functional study. Brain 125:199–214
Duffau H, Capelle L, Denvil D et al (2003) Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients. J Neuros 98:764–778
Sanai N, Eschbacher J, Hattendorf G, Coons SW, Preul MC, Smith KA, Nakaji P, Spetzler RF (2011) Intraoperative confocal microscopy for brain tumors: a feasibility analysis in humans. Neurosurgery 68:282–290; discussion 290
Mohammadi AM, Schroeder JL (2014) Laser interstitial thermal therapy in treatment of brain tumors—the NeuroBlate system. Expert Rev Med Devices 11:109–119
Stafford RJ, Fuentes D, Elliott AA, Weinberg JS, Ahrar K (2010) Laser-induced thermal therapy for tumor ablation. Crit Rev Biomed Eng 38:79–100
Carpentier A, Chauvet D, Reina V et al (2012) MR-guided laser-induced thermal therapy (LITT) for recurrent glioblastomas. Lasers Surg Med 44:361–368
Kalkanis SN, Kast RE, Rosenblum ML et al (2014) Raman spectroscopy to distinguish grey matter, necrosis, and glioblastoma multiforme in frozen tissue sections. J Neurooncol 116:477–485
Kircher MF, de la Zerda A, Jokerst JV et al (2012) A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nat Med 18:829–834
Acknowledgments
We thank our patients and their families for the inspiration, joy and sense of purpose they impart to us on a daily basis. The support, confidence and passion for life evident with each visit are truly gifts. We would like to thank Sandra Remer and Julie Ingram for their invaluable roles as nurse navigators, and Bridget O’ Connor, Stephanie Mintoff, Josie Jackson, Linda Gifford, Connie Kick, Lisa Scarpace and Denise Leung for their parts in providing excellent patient care. Special thanks to William (Alive in our hearts) and Karen Davidson, Eugene and Marcia Applebaum, David (Alive in our hearts) and Doreen Hermelin and their family, Ed and Julie (Alive in our hearts) Levy, Jay and Maryanne (Alive in our hearts) Alix, Todd and Linda Herrick, Michael and Leslie (Alive in our hearts) Indenbaum, Art and Mary Ann Van Elslander, Mark and Gayle (Alive in our hearts) (Halperin) Kahn, The Jeffries Family, Steve (Alive in our hearts) and Fair Radam, Mort and Brigitte Harris, Harold and Penny Blumenstein, Prashant (Alive in our hearts) and Saloni Fadia, James and Nancy Grosfeld, Joseph and Suzanne (Alive in our hearts) Orley, William and Barbara Belzberg, Martin Goldman, Graham and Sally Orley, and Joseph and Rosalie Vicari (Alive in our hearts).
Conflict of interest
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Robin, A.M., Kalkanis, S.N., Rock, J. et al. Through the patient’s eyes: an emphasis on patient-centered values in operative decision making in the management of malignant glioma. J Neurooncol 119, 473–479 (2014). https://doi.org/10.1007/s11060-014-1492-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-014-1492-4